Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 6 | 2019 | 10 | 2.610 |
Why?
|
| Gemfibrozil | 5 | 2017 | 8 | 1.880 |
Why?
|
| Microglia | 6 | 2023 | 25 | 1.780 |
Why?
|
| Animals | 19 | 2023 | 1349 | 1.750 |
Why?
|
| Mice | 15 | 2023 | 465 | 1.740 |
Why?
|
| Neurons | 5 | 2019 | 90 | 1.510 |
Why?
|
| Astrocytes | 5 | 2019 | 23 | 1.480 |
Why?
|
| Dopaminergic Neurons | 2 | 2023 | 12 | 1.440 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 19 | 1.390 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2018 | 8 | 1.390 |
Why?
|
| Aspirin | 2 | 2019 | 9 | 1.140 |
Why?
|
| Parkinson Disease | 3 | 2023 | 134 | 1.120 |
Why?
|
| Up-Regulation | 5 | 2023 | 54 | 1.070 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 3 | 2019 | 3 | 1.040 |
Why?
|
| Substantia Nigra | 2 | 2019 | 25 | 1.010 |
Why?
|
| Aminopeptidases | 2 | 2019 | 2 | 0.960 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2019 | 2 | 0.960 |
Why?
|
| Serine Proteases | 2 | 2019 | 3 | 0.960 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2017 | 3 | 0.840 |
Why?
|
| Cells, Cultured | 10 | 2021 | 167 | 0.810 |
Why?
|
| Multiple Sclerosis | 3 | 2017 | 15 | 0.810 |
Why?
|
| NF-kappa B | 6 | 2023 | 27 | 0.790 |
Why?
|
| Ascorbic Acid | 1 | 2023 | 23 | 0.780 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2023 | 2 | 0.770 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 222 | 0.700 |
Why?
|
| Humans | 15 | 2023 | 5837 | 0.700 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 36 | 0.670 |
Why?
|
| Brain | 5 | 2019 | 331 | 0.670 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 409 | 0.620 |
Why?
|
| Interleukin-12 | 2 | 2017 | 10 | 0.610 |
Why?
|
| Signal Transduction | 4 | 2021 | 139 | 0.610 |
Why?
|
| Mice, Knockout | 5 | 2021 | 103 | 0.590 |
Why?
|
| Cytokines | 4 | 2023 | 63 | 0.590 |
Why?
|
| Butyrates | 1 | 2019 | 1 | 0.590 |
Why?
|
| Cinnamates | 1 | 2019 | 2 | 0.580 |
Why?
|
| MPTP Poisoning | 1 | 2019 | 2 | 0.580 |
Why?
|
| Corpus Striatum | 1 | 2019 | 22 | 0.580 |
Why?
|
| Interleukin-11 | 1 | 2018 | 4 | 0.570 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 10 | 0.570 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 7 | 0.570 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 29 | 0.570 |
Why?
|
| Parkinsonian Disorders | 2 | 2019 | 43 | 0.560 |
Why?
|
| Oxidative Stress | 3 | 2023 | 25 | 0.540 |
Why?
|
| Interferon-gamma | 1 | 2017 | 12 | 0.530 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 13 | 0.530 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 5 | 0.510 |
Why?
|
| Sodium Chloride | 1 | 2017 | 12 | 0.510 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2017 | 12 | 0.490 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2007 | 4 | 0.470 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 2 | 0.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 18 | 0.440 |
Why?
|
| Peptides | 1 | 2015 | 22 | 0.440 |
Why?
|
| Apoptosis | 3 | 2017 | 65 | 0.410 |
Why?
|
| Hypolipidemic Agents | 2 | 2012 | 4 | 0.380 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2023 | 5 | 0.380 |
Why?
|
| Fenofibrate | 1 | 2012 | 2 | 0.380 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2009 | 7 | 0.370 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2023 | 12 | 0.370 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 13 | 0.330 |
Why?
|
| Inflammation | 3 | 2023 | 53 | 0.320 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2009 | 2 | 0.310 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 24 | 0.310 |
Why?
|
| Female | 5 | 2018 | 3346 | 0.290 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 1 | 0.290 |
Why?
|
| Cell Communication | 1 | 2009 | 10 | 0.290 |
Why?
|
| Cell Line | 3 | 2019 | 72 | 0.290 |
Why?
|
| Cell Movement | 1 | 2009 | 24 | 0.290 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 13 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 21 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 122 | 0.280 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 4 | 0.270 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 11 | 0.260 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 6 | 0.260 |
Why?
|
| Protein Binding | 2 | 2019 | 43 | 0.250 |
Why?
|
| AIDS Dementia Complex | 1 | 2007 | 24 | 0.250 |
Why?
|
| Myelin Basic Protein | 1 | 2005 | 3 | 0.230 |
Why?
|
| Th1 Cells | 2 | 2018 | 6 | 0.220 |
Why?
|
| Mutation | 2 | 2021 | 101 | 0.220 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2004 | 4 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 66 | 0.210 |
Why?
|
| HIV-1 | 1 | 2004 | 74 | 0.210 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2015 | 5 | 0.210 |
Why?
|
| Lysosomes | 2 | 2015 | 10 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 21 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2023 | 5 | 0.200 |
Why?
|
| Fruit | 1 | 2023 | 9 | 0.200 |
Why?
|
| HEK293 Cells | 1 | 2023 | 11 | 0.200 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 53 | 0.200 |
Why?
|
| tau Proteins | 1 | 2023 | 36 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 110 | 0.180 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 7 | 0.180 |
Why?
|
| Multiple System Atrophy | 1 | 2021 | 10 | 0.170 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 29 | 0.170 |
Why?
|
| Nitric Oxide | 3 | 2009 | 24 | 0.160 |
Why?
|
| Nitric Oxide Synthase | 2 | 1997 | 7 | 0.160 |
Why?
|
| Microbodies | 2 | 1996 | 2 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 9 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2018 | 7 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2018 | 15 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 5 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 17 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1 | 0.130 |
Why?
|
| Prostate | 1 | 2017 | 5 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 32 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 63 | 0.130 |
Why?
|
| Phytanic Acid | 2 | 1996 | 2 | 0.130 |
Why?
|
| Cyclic AMP | 1 | 1997 | 13 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2007 | 15 | 0.120 |
Why?
|
| Refsum Disease | 1 | 1996 | 1 | 0.120 |
Why?
|
| Chondrodysplasia Punctata, Rhizomelic | 1 | 1996 | 1 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2007 | 36 | 0.120 |
Why?
|
| Superoxides | 2 | 2007 | 3 | 0.120 |
Why?
|
| Child | 1 | 2017 | 339 | 0.120 |
Why?
|
| CCAAT-Binding Factor | 1 | 2015 | 2 | 0.110 |
Why?
|
| Chemokine CCL11 | 1 | 2015 | 2 | 0.110 |
Why?
|
| PPAR-beta | 1 | 2015 | 3 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2015 | 4 | 0.110 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 4 | 0.110 |
Why?
|
| Tretinoin | 1 | 2015 | 6 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 5 | 0.110 |
Why?
|
| Macaca mulatta | 1 | 2015 | 14 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2015 | 12 | 0.110 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2015 | 15 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 9 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 15 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 18 | 0.110 |
Why?
|
| Male | 2 | 2017 | 3399 | 0.110 |
Why?
|
| Autophagy | 1 | 2015 | 12 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2015 | 61 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 1034 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 94 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 20 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 13 | 0.090 |
Why?
|
| Middle Aged | 1 | 2017 | 1775 | 0.090 |
Why?
|
| Aged | 1 | 2017 | 1860 | 0.090 |
Why?
|
| Oxidation-Reduction | 3 | 2004 | 21 | 0.090 |
Why?
|
| Rats | 2 | 2007 | 282 | 0.090 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 1 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2010 | 4 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2010 | 3 | 0.080 |
Why?
|
| Macrophages | 1 | 2010 | 21 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 7 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 5 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 17 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 12 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 5 | 0.070 |
Why?
|
| Triglycerides | 1 | 2009 | 15 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 2 | 0.070 |
Why?
|
| Prions | 1 | 2007 | 2 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 2 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2007 | 3 | 0.070 |
Why?
|
| Poly I-C | 1 | 2007 | 4 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 11 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 41 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 4 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 5 | 0.060 |
Why?
|
| Fetus | 1 | 2007 | 8 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 14 | 0.060 |
Why?
|
| Mitochondria | 1 | 2007 | 19 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 22 | 0.060 |
Why?
|
| Pregnancy | 1 | 2007 | 103 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 189 | 0.060 |
Why?
|
| Castration | 1 | 2005 | 2 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 2 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2005 | 4 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 10 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2005 | 13 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 18 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 18 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 24 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2005 | 19 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 43 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 44 | 0.060 |
Why?
|
| Sex Factors | 1 | 2005 | 129 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2004 | 1 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 3 | 0.050 |
Why?
|
| Ceramides | 1 | 2004 | 3 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 11 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 12 | 0.050 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 9 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 86 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 36 | 0.050 |
Why?
|
| Fibroblasts | 2 | 1996 | 10 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1997 | 1 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 1997 | 1 | 0.030 |
Why?
|
| Colforsin | 1 | 1997 | 5 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 8 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 18 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1997 | 48 | 0.030 |
Why?
|
| Coenzyme A | 1 | 1996 | 1 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1996 | 1 | 0.030 |
Why?
|
| Biological Transport | 1 | 1996 | 15 | 0.030 |
Why?
|
| Reference Values | 1 | 1996 | 45 | 0.030 |
Why?
|
| Catalase | 1 | 1995 | 1 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 5 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 2 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 51 | 0.030 |
Why?
|
| Penicillamine | 1 | 1995 | 1 | 0.010 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1995 | 1 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 4 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 75 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1995 | 13 | 0.010 |
Why?
|
| Skin | 1 | 1995 | 40 | 0.010 |
Why?
|